Sporadic ret-rearranged papillary carcinoma of the thyroid: A subset of slow growing, less aggressive thyroid neoplasms?

Journal of Pathology

Volumn 185, Issue 1, 1998, Pages 71-78

  Soares, Paula ^a   Fonseca, Elsa ^a   Wynford Thomas, David ^b   Sobrinho Simões, Manuel ^a  

^a University of Porto   (Portugal)

^b CARDIFF UNIVERSITY   (United Kingdom)

Author keywords

Bcl 2; c met; c erb B2; E cadherin; MIB 1; Papillary carcinoma; Ret oncogene; Thyroid

Indexed keywords

ONCOPROTEIN; PROTEIN BCL 2; UVOMORULIN; VIMENTIN;

ADULT; AGE; ARTICLE; CANCER GROWTH; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE REARRANGEMENT; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; PRIORITY JOURNAL; PROTO ONCOGENE; THYROID PAPILLARY CARCINOMA;

ADOLESCENT; ADULT; AGED; BLOTTING, SOUTHERN; CADHERINS; CARCINOMA, PAPILLARY; DROSOPHILA PROTEINS; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE REARRANGEMENT; HUMANS; IMMUNOENZYME TECHNIQUES; MALE; MIDDLE AGED; PROTO-ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS C-RET; RECEPTOR PROTEIN-TYROSINE KINASES; THYROID NEOPLASMS; TUMOR MARKERS, BIOLOGICAL;

EID: 0031780414     PISSN: 00223417     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-9896(199805)185:1<71::AID-PATH42>3.0.CO;2-S     Document Type: Article

References (37)

1. Hay ID. Papillary thyroid carcinoma. Endocrinol Metab Clin North Am 1990; 19: 545-576.
2. Sobrinho-Simões M. Tumours of the thyroid. A brief overview with emphasis in the most controversial issues. Curr Diagn Pathol 1995; 2: 15-22.
3. Fusco A, Grieco M, Santoro M, et al. A new oncogene in human thyroid PTCs and their lymph node metastases. Nature 1987; 328: 170-172.
4. Grieco M, Santoro M, Berlingieri MT, et al. PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thryoid papillary carcinomas. Cell 1990; 60: 557-563.
5. Bongarzone I, Butti MG, Coronelli S, et al. Frequent activation of ret protooncogene by fusion with a new activating gene in papillary thyroid carcinomas. Cancer Res 1994; 54: 2979-2985.
6. Sozzi G, Bongarzone I, Miozzo M, et al. A t( 10;17) translocation creates the RET/PTC2 chimeric transforming sequence in papillary thyroid carcinoma. Genes Chrom Cancer 1994; 9: 244-250.
7. Jhiang SM, Smanik P, Mazzaferri E. Development of a single-step duplex rt-PCR detecting different forms of the third form of in vivo ret activation in human papillary thyroid carcinoma. Cancer Lett 1994; 78: 69-76.
8. Fugazzola L, Pierotti M, Vigano E, Pacini F, Vorontsova T, Bongarzone I. Molecular and biochemical analysis of RET/PTC4, a novel oncogenic rearrangement between RET and ELE1 genes, in a post-Chernobyl papillary thyroid cancer. Oncogene 1996; 13: 1093-1097.
9. Klugbauer S, Lengfelder E, Demidchik EP, Rabes HM. A new form of ret rearrangement in thyroid carcinomas of children after the Chernobyl reactor accident. Oncogene 1996; 13: 1099-1102.
10. Trupp M, Arenas E, Fainzilber M, el at. Functional receptor for GDNF encoded by the c-ret proto-oncogene. Nature 1996; 381: 785-789.
11. Santoro M, Carlomagno F, Hay ID, et al. RET oncogene activation in human thyroid neoplasms is restricted to the papillary cancer subtype. J Clin Invest 1992; 89: 1517-1522.
12. Santoro M, Sabino N, Ishizaka Y, et al. Involvement of ret oncogene in human tumours: specificity of ret activation to thyroid tumours. Br J Cancer 1993; 68: 460-464.
13. Santoro M, Tallini G, Carlomagno F, et al. Activation of the RET proto-oncogene in human thyroid tumours. J Endocrinol Invest 1996; 19 (Suppl to No 6): 4.
14. Bongarzone I, Fugazzola L, Vigneri P, et al. Age-related activation of the tyrosine kinase receptor proto-oncogenes ret and ntrkl in papillary thyroid carcinoma. J Clin Endocrinol 1996; 81: 2006-2009.
15. Williams GH, Thomas GA, Voscoboinik L, et al. Rearrangements of the RET oncogene in papillary carcinoma and gender. J Endocrinol Invest 1996; 19 (Suppl to No 6): 6.
16. Viglietto G, Chiappetta G, Martinez-Tello F, et al. RET/PTC oncogene activation is an early event in thyroid carcinogenesis. Oncogene 1995; 11: 1207-1210.
17. Mayr B, Pötter E, Goretzki P, et al. Prognostic value of ret-proto-oncogene activation in papillary thyroid carcinoma. J Endocrinol Invest 1996; 19 (Suppl to No 6): 57.
18. TPC oncogene in human thyroid cancers. Oncogene 1992; 7: 1331-1337.
19. Sugg SL, Zheng L, Rosen IB, Freeman JL, Ezzat S, Asa SL. ret/PTC-1, -2 and -3 oncogene rearrangement in human thyroid carcinomas: implications for metastatic potential? J Clin Endocrinol Metab 1996; 81: 3360-3365.
20. Hedinger C, Williams ED, Sobin LH, (eds). Histologic Typing of Thyroid Tumours. 2nd edn. World Health Organization - International Histologic Classification of Tumors. Berlin: Springer-Verlag, 1988.
21. Mullenbach R, Weldar C, Lagoda P. An efficient salt chloroform extraction of DNA from blood and tissues. Trends Genet 1989; 5: 391.
22. Holm R, Sobrinho-Simões M, Nesland JM, Gould VE, Johannessen V. Medullary carcinoma of the thyroid gland. An immunohistochemical study. Ultrastruct Pathol 1985; 8: 25-41.
23. Soares P, Berx G, Van Roy F, Sobrinho-Simões M. E-cadherin gene alterations are rare events in thyroid tumors. Int J Cancer 1997; 70: 32-38.
24. Bongarzone I, Pierotti MA, Monzini N, et al. High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma. Oncogene 1989; 4: 1457-1462.
25. Wajjwalku W, Nakamura S, Hasegawa Y, et al. Low frequency of rearrangements of the ret and trk proto-oncogenes in Japanese thyroid PTCs. Jpn J Cancer Res 1992; 83: 671-675.
26. TPC) in papillary thyroid carcinomas from Saudi Arabia. Cancer 1994; 73: 176-180.
27. Nikiforov Y, Gnepp DR. Pediatric thyroid cancer after the Chernobyl disaster. Cancer 1994; 74: 748-766.
28. Klugbauer S, Lengfelder E, Demidchik EP, Rabes HM. High prevalence of ret rearrangement in thyroid tumors of children from Belarus after the Chernobyl reactor accident. Oncogene 1995; 11: 2459-2467.
29. Bond JA, Wyllie FS, Rowson J, Radulescu A, Wynford-Thomas D. In vitro reconstruction of tumour initiation in a human epithelium. Oncogene 1994; 9: 281-290.
30. Jhiang SM, Sagartz JE, Tong Q, et al. Targeted expression of the ret/ptc1 oncogene induces papillary thyroid carcinomas. Endocrinology 1996; 137: 375-378.
31. Woolner LB, Lemmon ML, Bearhs OH, Black BM, Keating FR. Occult papillary carcinoma of the thyroid gland - a study of 140 cases observed in a 30-year period. J Clin Endocrinol Metab 1960; 20: 89-105.
32. Sobrinho-Simões M, Sambade MC, Gonçalves V. Latent thyroid carcinoma at autopsy. A study from Oporto, Portugal. Cancer 1979; 43: 1702-1706.
33. Fagin JA, Matsuo K, Karmakar A, Chen DL, Tang SH, Koeffler HP. High prevalence of mutation of p53 gene in poorly differentiated human thyroid carcinomas. J Clim Invest 1993; 91: 179-184.
34. Matias-Guiu X, Cuatrecasas M, Musulen E, Prat J. p53 expression in anaplastic carcinoma arising from thyroid papillary carcinomas. J Clin Pathol 1994; 47: 377-339.
35. Williams ED. Pathology and molecular biology of post Chernobyl thyroid carcinoma. J Endocrinol Invest 1996; 19 (Suppl to No 6): 4.
36. Di Renzo MF, Olivero M, Ferro S, et al. Overexpression of the c-MET/ HGF receptor gene in human thryoid carcinomas. Oncogene 1992; 7: 2549-2553.
37. Soares P, Sambade C, Sobrinho-Simões M. Expression of c-erb B2 in tumours and tumour-like lesions of the thyroid. Int J Cancer 1994; 56: 459-461.